NO161618C - Analogifremgangsm te for fremstilling av terapeutisk aktive fenylalkyl-(piperazinyl eller homopiperazinyl)-alkyl-(urinstoff eller tiourinstoff)-derivater. - Google Patents

Analogifremgangsm te for fremstilling av terapeutisk aktive fenylalkyl-(piperazinyl eller homopiperazinyl)-alkyl-(urinstoff eller tiourinstoff)-derivater.

Info

Publication number
NO161618C
NO161618C NO842417A NO842417A NO161618C NO 161618 C NO161618 C NO 161618C NO 842417 A NO842417 A NO 842417A NO 842417 A NO842417 A NO 842417A NO 161618 C NO161618 C NO 161618C
Authority
NO
Norway
Prior art keywords
tiourine
homopiperazinyl
phenylalkyl
piperazinyl
urine
Prior art date
Application number
NO842417A
Other languages
English (en)
Norwegian (no)
Other versions
NO161618B (no
NO842417L (no
Inventor
John P Devlin
Karl D Hargrave
Edward L Barsumian
Genus J Possanza
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Publication of NO842417L publication Critical patent/NO842417L/no
Publication of NO161618B publication Critical patent/NO161618B/no
Publication of NO161618C publication Critical patent/NO161618C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO842417A 1983-06-16 1984-06-15 Analogifremgangsm te for fremstilling av terapeutisk aktive fenylalkyl-(piperazinyl eller homopiperazinyl)-alkyl-(urinstoff eller tiourinstoff)-derivater. NO161618C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50483783A 1983-06-16 1983-06-16

Publications (3)

Publication Number Publication Date
NO842417L NO842417L (no) 1984-12-17
NO161618B NO161618B (no) 1989-05-29
NO161618C true NO161618C (no) 1989-09-06

Family

ID=24007953

Family Applications (1)

Application Number Title Priority Date Filing Date
NO842417A NO161618C (no) 1983-06-16 1984-06-15 Analogifremgangsm te for fremstilling av terapeutisk aktive fenylalkyl-(piperazinyl eller homopiperazinyl)-alkyl-(urinstoff eller tiourinstoff)-derivater.

Country Status (25)

Country Link
EP (1) EP0129207B1 (da)
JP (1) JPS6075469A (da)
KR (1) KR890000175B1 (da)
AR (1) AR242377A1 (da)
AT (1) ATE33023T1 (da)
AU (1) AU565041B2 (da)
CA (1) CA1219260A (da)
CS (1) CS244821B2 (da)
DD (1) DD223710A5 (da)
DE (1) DE3469896D1 (da)
DK (1) DK160554C (da)
ES (3) ES533448A0 (da)
FI (1) FI76327C (da)
GR (1) GR82367B (da)
HU (1) HU192409B (da)
IE (1) IE59034B1 (da)
IL (1) IL72123A (da)
NO (1) NO161618C (da)
NZ (1) NZ208535A (da)
PH (1) PH24059A (da)
PL (2) PL146314B1 (da)
PT (1) PT78729B (da)
SU (2) SU1542415A3 (da)
YU (2) YU104584A (da)
ZA (1) ZA844527B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661481A (en) * 1983-06-16 1987-04-28 Boehringer Ingelheim Pharmaceuticals, Inc Substituted phenylalkylhomopiperazinylpropyl(ureas or thioureas) useful for treatment of immulogical, inflammatory and allergic disorders
FR2601366B1 (fr) * 1986-07-10 1988-11-25 Andre Buzas Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant.
JP2722250B2 (ja) * 1989-05-30 1998-03-04 興和株式会社 新規なジアミン化合物及びこれを含有する脳機能障害改善剤
JPH0525145A (ja) * 1991-07-15 1993-02-02 Mochida Pharmaceut Co Ltd アレルギー性疾患治療剤
JP3719612B2 (ja) * 1993-06-14 2005-11-24 塩野義製薬株式会社 ヘテロ環を含有する尿素誘導体
ITRM20060090A1 (it) * 2006-02-22 2007-08-23 Sigma Tau Ind Farmaceuti Nuovi composti inibitori cpt a livello del snc come farmaci antidiabetici e o antiobesita
TW201446748A (zh) 2007-08-22 2014-12-16 Astrazeneca Ab 環丙基醯胺衍生物
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
BR112012020629A2 (pt) 2010-02-18 2018-06-19 Astrazeneca Ab forma cristalina, e, método para a terapia de um distúrbio
US10662181B2 (en) 2016-07-13 2020-05-26 Leo Pharma A/S Heteroaromatic modulators of the retinoid-related orphan receptor gamma

Also Published As

Publication number Publication date
DK160554C (da) 1991-09-09
NZ208535A (en) 1987-02-20
PL248207A1 (en) 1985-08-13
PL252851A1 (en) 1986-07-01
CS244821B2 (en) 1986-08-14
ZA844527B (en) 1986-02-26
AR242377A1 (es) 1993-03-31
NO161618B (no) 1989-05-29
EP0129207A3 (en) 1985-07-31
AU2940484A (en) 1984-12-20
DD223710A5 (de) 1985-06-19
ES8506651A1 (es) 1985-08-01
ES537662A0 (es) 1985-09-16
PT78729A (en) 1984-07-01
IE59034B1 (en) 1993-12-15
AU565041B2 (en) 1987-09-03
JPS6075469A (ja) 1985-04-27
ES533448A0 (es) 1985-08-01
EP0129207B1 (en) 1988-03-16
FI842408A0 (fi) 1984-06-14
EP0129207A2 (en) 1984-12-27
FI76327B (fi) 1988-06-30
ATE33023T1 (de) 1988-04-15
HUT34464A (en) 1985-03-28
DE3469896D1 (en) 1988-04-21
YU150186A (en) 1987-06-30
PL147413B1 (en) 1989-05-31
ES8600255A1 (es) 1985-09-16
JPH0469147B2 (da) 1992-11-05
YU104584A (en) 1986-12-31
PT78729B (en) 1986-10-21
CA1219260A (en) 1987-03-17
HU192409B (en) 1987-06-29
FI842408A (fi) 1984-12-17
SU1387877A3 (ru) 1988-04-07
KR890000175B1 (ko) 1989-03-09
PL146314B1 (en) 1989-01-31
ES537661A0 (es) 1985-11-01
IL72123A (en) 1987-09-16
IE841499L (en) 1984-12-16
IL72123A0 (en) 1984-10-31
NO842417L (no) 1984-12-17
SU1542415A3 (ru) 1990-02-07
DK294084A (da) 1984-12-17
ES8601928A1 (es) 1985-11-01
FI76327C (fi) 1988-10-10
DK294084D0 (da) 1984-06-15
GR82367B (da) 1984-12-13
KR850000422A (ko) 1985-02-27
DK160554B (da) 1991-03-25
PH24059A (en) 1990-03-05

Similar Documents

Publication Publication Date Title
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO810765L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO156785B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO842273L (no) Fremgangsmaate ved fremstilling av aminomethyloxooxazolidinylbenzenderivater.
NO874764L (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO159166C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoazepinderivater.
NO162073C (no) Analogifremgangsmaate for fremstilling av farmakologiske aktive heterocykliske forbindelser.
NO167200C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive urinstoff-forbindelser.
NO165027C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenyl-cefalosporinforbindelser.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO822932L (no) Analogifremgangsmaate for fremstilling av heterocykliske benzoforbindelser.
NO161317C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO161066C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
NO161618C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive fenylalkyl-(piperazinyl eller homopiperazinyl)-alkyl-(urinstoff eller tiourinstoff)-derivater.
NO822634L (no) Fremgangsmaate for fremstilling av cefemderivater.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO155693C (no) Fremgangsmaate for fremstilling av eburnamoninderivater.
NO851920L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO167980C (no) Analogifremgangsmaate for fremstilling av tienoimidazol-derivater.
NO159273C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzotriazol-derivater.
NO158063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2000